Test Price
2,500 AED✅ Home Collection Available
HLA Pre-Transplant Workup (Non-Sensitized Recipient Panel) in Dubai, UAE
Executive Summary & Core Metrics
Core Metrics Overview
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via Complement-Dependent Cytotoxicity (CDC) and Luminex X-Map Technology, processed in an ISO 9001:2015 certified laboratory facility.
- Premium Logistics: VIP Mobile Phlebotomy and Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary telephonic post-test clinical guidance for result interpretation with a Consultant Medical Genetics professional.
- Insurance Billing: Direct billing verification and fast-track approval available via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
Clinical Rationale
The HLA Pre-Transplant Workup evaluates human leukocyte antigen compatibility between a non-sensitized transplant recipient and a potential donor using complement-dependent cytotoxicity and high-resolution Luminex SSOP technology. This panel identifies donor-specific antibodies and mismatched HLA alleles to prevent hyperacute rejection, ensuring safe kidney transplantation under current DHA guidelines.
Methodological Differentiation
Our laboratory employs a dual-methodology approach combining CDC with DTT-treated serum to eliminate IgM interference and Luminex X-Map reverse SSOP for high-resolution antibody detection. This integrated platform provides superior sensitivity over standard flow cytometry crossmatch alone, enabling detection of low-level donor-specific antibodies that conventional assays miss.
| Parameter | Our Test (DNA Labs UAE) | Closest Alternative |
|---|---|---|
| Precision | CDC + Luminex SSOP and X-Map, DTT-treated serum | Flow cytometry crossmatch alone |
| Methodology | Complement-Dependent Cytotoxicity, Reverse SSOP Luminex, Triplet analysis | Basic lymphocytotoxicity assay |
| Turnaround Time | 10–12 days | 14–21 days |
| Home Collection | VIP Mobile Phlebotomy, Temperature-Controlled Cold-Chain, 8 AM–11 PM | Standard lab visit only |
Physician Insight & Safety Protocols
“HLA compatibility assessment forms the immunological cornerstone of successful solid organ transplantation. The non-sensitized recipient panel provides a critical baseline that allows transplant teams to stratify risk and optimize immunosuppressive protocols. No single laboratory parameter defines transplant candidacy; results must be interpreted in conjunction with renal function, medication adherence, and comprehensive clinical evaluation. Always consult your transplant nephrologist before making any therapeutic adjustments.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Precautions
Do not discontinue prescribed immunosuppressive or antihypertensive medication without consulting your doctor. Sudden changes can precipitate rejection crisis or hypertensive emergency. This test serves as a diagnostic aid and should not replace ongoing clinical management by your transplant team.
Safety Exclusion Criteria and Emergency Red Flags
- Active systemic infection or untreated sepsis.
- Recent live vaccination within four weeks.
- Pregnancy or breastfeeding where certain contrast agents may be contraindicated.
- Known severe bleeding diathesis or haemodynamic instability.
- If you develop fever exceeding 38.5°C, new-onset rash, or difficulty breathing after sample collection, seek immediate emergency care.
Patient FAQ & Clinical Guidance
1. What is the purpose of this pre-transplant workup if I have never been pregnant or received a blood transfusion?
Even without known sensitizing events, unrecognized antibodies to HLA or minor antigens can still trigger early graft injury. This comprehensive panel detects those hidden risks using CDC crossmatch with DTT to eliminate IgM interference combined with Luminex technology that identifies low-level donor-specific antibodies standard tests miss. This dual-layer approach ensures a safe transplant window and guides immunosuppressive strategy.
2. How should I prepare for the blood collection at home?
Schedule collection at least 48 hours after your last dialysis session, remain well-hydrated, and have all documents ready including your prescription, signed consent form, and photographs. The phlebotomist will collect one ACD yellow top tube, one SST red or gold top tube, and one EDTA lavender top tube. Keep samples refrigerated until pickup; never freeze them. Our temperature-controlled cold-chain logistics ensure specimen integrity from your doorstep to our ISO-certified laboratory.
3. What do the results indicate and how quickly can the transplant proceed?
A negative CDC crossmatch and undetectable donor-specific antibodies on Luminex indicate a high probability of immediate graft acceptance, and transplantation can often be scheduled within days. Positive results require further testing or desensitization protocols. Your transplant team will correlate these findings with your overall risk profile and donor availability to determine the exact timeline for surgery.
UAE Regulatory & Data Privacy Adherence
Data Protection Framework: Your personal health information is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and processed exclusively for diagnostic purposes. All electronic health data handling complies with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensuring secure transmission, storage, and access control.
Clinical Safety and Consent: Patient safety and informed consent protocols adhere strictly to Federal Decree-Law No. 4 of 2016 on Medical Liability, which governs clinical testing standards and patient rights throughout the UAE healthcare system.
Laboratory Accreditation: DNA Labs UAE operates under DHA Facility License Number 1143 and maintains ISO 9001:2015 certification, demonstrating commitment to quality management and continuous improvement in diagnostic services.
Clinical & Logistical Metadata
| Test Name | HLA Pre-Transplant Workup (Non-Sensitized Recipient Panel) |
| Price (AED) | 2,500 |
| Turnaround Time | 10–12 business days |
| Sample Type / Matrix | Whole blood – 6 mL in ACD yellow top tube, 3 mL serum in SST red/gold top tube, 4 mL whole blood in EDTA lavender top tube. Ship refrigerated. Do not freeze. |
| Methodology Used | Complement-Dependent Cytotoxicity with DTT-treated serum, Luminex X-Map reverse SSOP, Triplet analysis |
| ICD-10-CM Code | Z01.81 (Encounter for preprocedural examination) |
| LOINC Code | 48669-3 (HLA crossmatch interpretation) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians